Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of the Glycine Transporter-1 Inhibitor Iclepertin (BI 425809) on Sensory Processing, Neural Network Function, and Cognition in Animal Models Related to Schizophrenia
Holger Rosenbrock, Cornelia Dorner‐Ciossek, Riccardo Giovannini, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 382, Iss. 2, pp. 223-232
Open Access | Times Cited: 17

Showing 17 citing articles:

Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia
Holger Rosenbrock, Michael Desch, Glen Wunderlich
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1557-1566
Open Access | Times Cited: 43
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 16
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13
Beyond dopamine: Novel strategies for schizophrenia treatment
Paulina Dudzik, Klaudia Lustyk, Karolina Pytka
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2307-2330
Closed Access | Times Cited: 12
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications
Clément Dondé, Joshua T. Kantrowitz, Alice Medalia, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105098-105098
Open Access | Times Cited: 19
Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors
Dolores Piniella, Francisco Zafra
Neuropharmacology (2023) Vol. 232, pp. 109514-109514
Open Access | Times Cited: 19
Antibiotics treatment promotes vasculogenesis in the brain of glioma-bearing mice
Maria Rosito, Javeria Maqbool, A. Reccagni, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 7
IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective
Veronica Begni, Alessia Marchesin, Marco Andrea Riva
Pharmacological Research (2025), pp. 107690-107690
Open Access
Modulation of the human GlyT1 by clinical drugs and cholesterol
Na Li, Yiqing Wei, Renjie Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities
Na Ye, Qi Wang, Yue Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
Discovery of VU6024578/BI02982816: An mGlu1 Positive Allosteric Modulator with Efficacy in Preclinical Antipsychotic and Cognition Models
Carson W. Reed, Jacob F. Kalbfleisch, Jeremy A. Turkett, et al.
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 1
The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: Protocol for an updated systematic review and meta-analysis
Xinxing Fei, Shiqi Wang, Jiyang Li, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283185-e0283185
Open Access | Times Cited: 3
Differential Effects of Aripiprazole on Electroencephalography-Recorded Gamma-Band Auditory Steady-State Response, Spontaneous Gamma Oscillations and Behavior in a Schizophrenia Rat Model
Florian W. Adraoui, Kenza Hettak, Geoffrey Viardot, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1035-1035
Open Access
N-Methyl-d-Aspartate Receptor Antibody and Sensory Gating Deficits in Non-smoking, Minimal Antipsychotic Medication Exposure, and First-Episode Patients With Schizophrenia
Jinghui Tong, Kebing Yang, Wei Li, et al.
Schizophrenia Bulletin (2024)
Open Access
Org24598, a Selective Glycine Transporter 1 (GlyT1) Inhibitor, Reverses Object Recognition and Spatial Memory Impairments Following Binge-like Ethanol Exposure in Rats
Joanna Filarowska-Jurko, Paweł Grochecki, Ewa Gibuła‐Tarłowska, et al.
Molecules (2024) Vol. 29, Iss. 24, pp. 6017-6017
Open Access
The protective effect of N-acetylcysteine against MK-801-induced neurodegeneration in mice
Murat Sırrı AKOSMAN, Ruhi Türkmen, Hasan Hüseyin Demirel
Molecular Biology Reports (2023) Vol. 50, Iss. 12, pp. 10287-10299
Closed Access
Page 1

Scroll to top